AGR Summary
Bio-Rad Laboratories, Inc.
(NYSE:BIO)
Average
(67)
| Industry: | Medical Equipment / Supplies / Distribution | Period End: | Mar 31, 2010 (Fiscal 2010 Q-1) | Statement Filing: | May 10, 2010 (10-Q) |
|---|---|---|---|---|---|
| Market Cap: | USD 1,916.8mm (Mid Cap) | Last Audit: | Ernst & Young LLP | Rating Published: | Jun 18, 2010 |
OVERVIEW
Bio-Rad Laboratories, Inc.
is currently rated as having
Average Accounting & Governance Risk (AGR).
This places them in the 67th
percentile among all companies, indicating higher accounting and governance risk than
33% of companies.
RISK SUMMARY
The forensic risk summary highlights material risks, if any, and lists the most material red flagged metric for each risk. AGR Impact shows the relative weight of the various red flagged metrics by risk type.
| Risk | AGR Impact | Top Flagged Metric |
|---|---|---|
| Corporate Governance Events | 16.3% | Comp: CEO /CFO Total Comp |
| High Risk Events | 39.0% | Abnormal Change in Employee Count |
| Revenue Recognition | 19.8% | Work in Progress/Revenue |
| Expense Recognition | 24.9% | Prepaid Expenses/Operating Expense |
| Asset-Liability Valuation | 0.0% |